<abstract xmlns="http://www.w3.org/1999/xhtml"><p>From the onset of the first case until now, HIV infection is one of the most studied pathologies in the medical field, due to the incompletely known action of the virus per se, as well as the comorbidities associated with it. Currently, a field of interest in research is occupied by cardiovascular comorbidities, being more and more frequent at PLWH. From the pathophysiological mechanisms of action, the traditional and modern CV risk factors, the scores with relative predictability to the adverse effects of ARV therapy, CVD at PLWH represent an incomplete studied field, which requires further investigation.</p></abstract>

From the onset of the first case until now, HIV infection is one of the most studied pathologies in the medical field, due to the incompletely known action of the virus per se, as well as the comorbidities associated with it. Currently, a field of interest in research is occupied by cardiovascular comorbidities, being more and more frequent at PLWH. From the pathophysiological mechanisms of action, the traditional and modern CV risk factors, the scores with relative predictability to the adverse effects of ARV therapy, CVD at PLWH represent an incomplete studied field, which requires further investigation.

Cardiovascular Risk Assessment in HIV-Infected Patients

ARS Medica Tomitana

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

{"article-title":"Cardiovascular Risk Assessment in HIV-Infected Patients"}

From the onset of the first case until now, HIV infection is one of the most studied pathologies in the medical field, due to the incompletely known action of...

Cardiovascular Risk Assessment in HIV-Infected Patients

Pubblicato online: 22 apr 2021

Pagine: 5 - 9

DOI: https://doi.org/10.2478/arsm-2020-0002

Parole chiave
Cardiovascular, risk factors, HIV, patients, comorbidities, scores, heart failure, antiretroviral therapy

© 2020 Zekra Lucia et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Cardiovascular Risk Assessment in HIV-Infected Patients

Pubblicato online: 22 apr 2021

Pagine: 5 - 9

DOI: https://doi.org/10.2478/arsm-2020-0002

Parole chiaveCardiovascular, risk factors, HIV, patients, comorbidities, scores, heart failure, antiretroviral therapy

© 2020 Zekra Lucia et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Parole chiave
Cardiovascular, risk factors, HIV, patients, comorbidities, scores, heart failure, antiretroviral therapy